Table 1.
Demographic and pre-treatment clinical variables according to type of transfusions given.
| ABO Matched, Leukoreduced | ABO Matched, Leukoreduced, Washed | P value by Mann Whitney or Fisher's Exact Test | |
| N | 18 | 25 | |
| Age | 48 ± 23 | 47 ± 17 | 0.89 |
| Male | 9 (50%) | 11 (44%) | 0.76 |
| ALL/AML | 4/14 | 5/20 | 0.99 |
| Antecedent Hematologic Disorder (MDS) | 0 of 18 (0%) | 3 of 25 (12%) | 0.25 |
| Favorable Risk Cytogenetics | 1 (6%) | 0 (0%) | 0.09* |
| Standard Risk Cytogenetics | 6 (33%) | 7 (28%) | |
| Poor Risk Cytogenetics | 2 (11%) | 11 (44%) | |
| Unknown Cytogenetics | 9 (50%) | 7 (28%) | |
| Admission Blast Count (×1000/μl) | 25 ± 36 | 23 ± 41 | 0.59 |
All data are mean ± 1 SD. MDS = myelodysplastic syndrome
*For cytogenetics as a category overall